Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-12-28 4:16 pm Purchase |
2023-12-26 | 13G | KalVista Pharmaceuticals, Inc. KALV |
Venrock Healthcare Capital Partners III L.P. | 3,573,714 10.300% |
657,047 (+22.53%) |
Filing History |
| 2023-12-14 1:33 pm Purchase |
2023-12-12 | 13D | KalVista Pharmaceuticals, Inc. KALV |
Frazier Life Sciences Public Fund, L.P. | 3,582,294 10.400% |
343,435 (+10.60%) |
Filing History |
| 2023-03-10 5:15 pm Purchase |
2023-01-25 | 13G | KalVista Pharmaceuticals, Inc. KALV |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,796,379 5.300% |
724,077 (+67.53%) |
Filing History |
| 2023-02-14 4:59 pm Sale |
2022-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV |
Great Point Partners, LLC | 1,055,801 3.100% |
-224,199 (-17.52%) |
Filing History |
| 2023-02-14 4:00 pm Purchase |
2022-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV |
TANG CAPITAL PARTNERS LP | 3,196,446 9.400% |
1,796,446 (+128.32%) |
Filing History |
| 2023-02-14 08:41 am Sale |
2022-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV |
Deep Track Capital, LP | 0 0.000% |
-1,500,000 (Position Closed) |
Filing History |
| 2023-02-13 5:44 pm Purchase |
2022-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV |
Vivo Capital IX, LLC | 772,068 2.300% |
772,068 (New Position) |
Filing History |
| 2023-02-13 10:51 am Sale |
2022-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,072,302 3.100% |
-673,998 (-38.60%) |
Filing History |
| 2023-02-09 11:18 am Purchase |
2023-02-09 | 13G | KalVista Pharmaceuticals, Inc. KALV |
FMR LLC | 1,311,002 5.325% |
299,502 (+29.61%) |
Filing History |
| 2023-02-06 3:02 pm Sale |
2022-12-30 | 13G | KalVista Pharmaceuticals, Inc. KALV |
Wellington Management Group LLP | 0 0.000% |
-1,811,505 (Position Closed) |
Filing History |
| 2023-01-31 2:18 pm Sale |
2022-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV |
FRANKLIN RESOURCES INC BEN |
0 0.000% |
-1,252,142 (Position Closed) |
Filing History |
| 2023-01-09 4:19 pm Purchase |
2022-12-28 | 13D | KalVista Pharmaceuticals, Inc. KALV |
TCG Crossover GP I, LLC | 3,408,081 9.900% |
3,408,081 (New Position) |
Filing History |
| 2023-01-09 4:06 pm Purchase |
2022-12-28 | 13G | KalVista Pharmaceuticals, Inc. KALV |
Venrock Healthcare Capital Partners III L.P. | 2,916,667 8.600% |
2,916,667 (New Position) |
Filing History |
| 2023-01-06 1:46 pm Purchase |
2022-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV |
BlackRock Inc. BLK |
1,572,421 4.600% |
67,801 (+4.51%) |
Filing History |
| 2022-12-30 2:15 pm Purchase |
2022-12-28 | 13D | KalVista Pharmaceuticals, Inc. KALV |
Frazier Life Sciences Public Fund, L.P. | 3,238,859 9.500% |
1,666,667 (+106.01%) |
Filing History |
| 2022-08-15 5:12 pm Sale |
2022-08-15 | 13G | KalVista Pharmaceuticals, Inc. KALV |
RA Capital Management, L.P. | 0 0.000% |
-1,930,322 (Position Closed) |
Filing History |
| 2022-05-26 4:00 pm Purchase |
2022-05-16 | 13G | KalVista Pharmaceuticals, Inc. KALV |
TANG CAPITAL PARTNERS LP | 1,400,000 5.700% |
1,400,000 (New Position) |
Filing History |
| 2022-05-18 4:03 pm Purchase |
2022-05-09 | 13G | KalVista Pharmaceuticals, Inc. KALV |
Great Point Partners, LLC | 1,280,000 5.220% |
1,280,000 (New Position) |
Filing History |
| 2022-02-14 4:32 pm Sale |
2021-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV |
Ikarian Capital LLC | 36,576 0.200% |
-1,027,385 (-96.56%) |
Filing History |
| 2022-02-14 4:11 pm Purchase |
2021-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV |
RA Capital Management, L.P. | 1,930,322 7.900% |
530,833 (+37.93%) |
Filing History |